Structure and mechanism for recognition of peptide hormones by Class B G-protein-coupled receptors

被引:0
|
作者
Kuntal Pal
Karsten Melcher
H Eric Xu
机构
[1] Laboratory of Structural Sciences,
[2] Van Andel Research Institute,undefined
[3] VARI-SIMM Center,undefined
[4] Center for Structure and Function of Drug Targets,undefined
[5] State Key Laboratory of Drug Research,undefined
[6] Shanghai Institute of Materia Medica,undefined
[7] Chinese Academy of Sciences,undefined
来源
关键词
G-protein-coupled receptor (GPCR); parathyroid hormone; glucagon; calcitonin; crystal structure;
D O I
暂无
中图分类号
学科分类号
摘要
Class B G-protein-coupled receptors (GPCRs) are receptors for peptide hormones that include glucagon, parathyroid hormone, and calcitonin. These receptors are involved in a wide spectrum of physiological activities, from metabolic regulation and stress control to development and maintenance of the skeletal system. As such, they are important drug targets for the treatment of diabetes, osteoporosis, and stress related disorders. Class B GPCRs are organized into two modular domains: an extracellular domain (ECD) and a helical bundle that contains seven transmembrane helices (TM domain). The ECD is responsible for the high affinity and specificity of hormone binding, and the TM domain is required for receptor activation and signal coupling to downstream G-proteins. Although the structure of the full-length receptor remains unknown, the ECD structures have been well characterized for a number of Class B GPCRs, revealing a common fold for ligand recognition. This review summarizes the general structural principles that guide hormone binding by Class B ECDs and their implications in the design of peptide hormone analogs for therapeutic purposes.
引用
收藏
页码:300 / 311
页数:11
相关论文
共 50 条
  • [21] THE EVOLUTION AND STRUCTURE OF AMINERGIC G-PROTEIN-COUPLED RECEPTORS
    DONNELLY, D
    FINDLAY, JBC
    BLUNDELL, TL
    RECEPTORS & CHANNELS, 1994, 2 (01): : 61 - 78
  • [22] Modeling and predicting the structure of G-protein-coupled receptors
    Michino, M
    Im, W
    Chen, JH
    Brooks, CL
    BIOPHYSICAL JOURNAL, 2005, 88 (01) : 81A - 81A
  • [23] A novel subgroup of class I G-protein-coupled receptors
    Schöneberg, T
    Schulz, A
    Grosse, R
    Schade, R
    Henklein, P
    Schultz, G
    Gudermann, T
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1999, 1446 (1-2): : 57 - 70
  • [24] Structure-Based Discovery of Allosteric Modulators of Two Related Class B G-Protein-Coupled Receptors
    de Graaf, Chris
    Rein, Chantal
    Piwnica, David
    Giordanetto, Fabrizio
    Rognan, Didier
    CHEMMEDCHEM, 2011, 6 (12) : 2159 - 2169
  • [25] Pathway and mechanism of drug binding to G-protein-coupled receptors
    Dror, Ron O.
    Pan, Albert C.
    Arlow, Daniel H.
    Borhani, David W.
    Maragakis, Paul
    Shan, Yibing
    Xu, Huafeng
    Shaw, David E.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (32) : 13118 - 13123
  • [26] Activation of G-protein-coupled receptors: a common molecular mechanism
    Karnik, SS
    Gogonea, C
    Patil, S
    Saad, Y
    Takezako, T
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2003, 14 (09): : 431 - 437
  • [27] Pathway and Mechanism of Drug Binding to G-Protein-Coupled Receptors
    Dror, Ron O.
    Pan, Albert C.
    Arlow, Daniel H.
    Borhani, David W.
    Maragakis, Paul
    Shan, Yibing
    Xu, Huafeng
    Shaw, David E.
    BIOPHYSICAL JOURNAL, 2012, 102 (03) : 410A - 410A
  • [28] Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors
    Pin, JP
    Galvez, T
    Prézeau, L
    PHARMACOLOGY & THERAPEUTICS, 2003, 98 (03) : 325 - 354
  • [29] STRUCTURE AND MECHANISM OF THE G-PROTEIN-COUPLED RECEPTOR KINASES
    INGLESE, J
    FREEDMAN, NJ
    KOCH, WJ
    LEFKOWITZ, RJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (32) : 23735 - 23738
  • [30] Genetic variation in G-protein-coupled receptors - consequences for G-protein-coupled receptors as drug targets
    Tang, CM
    Insel, PA
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2005, 9 (06) : 1247 - 1265